Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Return on Capital Employed: 2011-2018

Historic Return on Capital Employed for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Sep 2018 value amounting to -0.58%.

  • EyePoint Pharmaceuticals' Return on Capital Employed rose 90.00% to -0.58% in Q3 2018 from the same period last year, while for Sep 2018 it was -0.58%, marking a year-over-year increase of 90.00%. This contributed to the annual value of -1.12% for FY2018, which is 18.00% down from last year.
  • EyePoint Pharmaceuticals' Return on Capital Employed amounted to -0.58% in Q3 2018, which was up 12.65% from -0.67% recorded in Q2 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Return on Capital Employed peaked at 0.36% during Q3 2014, and registered a low of -2.43% during Q4 2017.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Return on Capital Employed value was -1.08% (recorded in 2016), while the average stood at -1.25%.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Return on Capital Employed surged by 115bps in 2014 and then slumped by 135bps in 2017.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Return on Capital Employed stood at 0.26% in 2014, then tumbled by 120bps to -0.94% in 2015, then decreased by 14bps to -1.08% in 2016, then tumbled by 135bps to -2.43% in 2017, then soared by 90bps to -0.58% in 2018.
  • Its Return on Capital Employed was -0.58% in Q3 2018, compared to -0.67% in Q2 2018 and -2.06% in Q1 2018.